Location History:
- Yongin-si, KR (2022)
- Gyeonggi-do, KR (2017 - 2023)
Company Filing History:
Years Active: 2017-2023
Title: Daekwon Bae: Innovator in Pharmaceutical Composition
Introduction
Daekwon Bae is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating complex diseases. With a total of 5 patents to his name, Bae is recognized for his innovative approaches to medical treatments.
Latest Patents
One of Daekwon Bae's latest patents is focused on compositions for preventing or treating lupus. This invention relates to a pharmaceutical composition that includes a compound represented by a specific formula, which has shown excellent efficacy in preventing or treating lupus. The composition also outlines a treatment method using the compound and its application in manufacturing medicaments for lupus treatment.
Another notable patent involves heterocyclicalkyl derivative compounds that act as selective histone deacetylase inhibitors. This invention details novel heterocyclicalkyl derivatives with histone deacetylase (HDAC) inhibitory activity, along with their optical isomers and pharmaceutically acceptable salts. The patent describes the use of these compounds in preparing medicaments and pharmaceutical compositions for treating various diseases, including cell proliferative diseases, inflammatory diseases, and neurodegenerative diseases.
Career Highlights
Daekwon Bae is currently associated with Chong Kun Dang Pharmaceutical Corporation, where he continues to innovate in the pharmaceutical sector. His work has significantly impacted the development of new treatments for various medical conditions.
Collaborations
Bae collaborates with talented individuals in his field, including Nina Ha and Hyeseung Song. Their combined expertise contributes to the advancement of pharmaceutical innovations.
Conclusion
Daekwon Bae is a distinguished inventor whose work in pharmaceutical compositions has the potential to transform treatment options for serious diseases. His innovative patents reflect a commitment to improving healthcare through scientific advancements.